This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kabushiki Kaisha Yakult Honsha. Active years: 2008-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2008)
- Minato-ku, JP (2014)
Company Filing History:
Years Active: 2008-2014
Title: Yukiko Nishiyama: Innovator in Cancer Resistance Research
Introduction
Yukiko Nishiyama is a prominent inventor based in Minato-ku, Japan. She has made significant contributions to the field of cancer research, particularly in developing inhibitors for breast cancer resistance proteins. With a total of 2 patents, her work is paving the way for new therapeutic options in oncology.
Latest Patents
Nishiyama's latest patents include a BCRP/ABCG2 inhibitor, which targets the breast cancer resistance protein (BCRP/ABCG2). This innovative drug contains an acrylonitrile derivative or a salt thereof as its active ingredient. The invention aims to provide a drug that effectively inhibits BCRP, showcasing her commitment to advancing cancer treatment.
Career Highlights
Yukiko Nishiyama is associated with Kabushiki Kaisha Yakult Honsha, where she continues her research and development efforts. Her work has garnered attention in the scientific community, contributing to the understanding of drug resistance in breast cancer.
Collaborations
Nishiyama collaborates with notable colleagues, including Ryuta Yamazaki and Tomio Furuta. Their combined expertise enhances the research environment and fosters innovation in their projects.
Conclusion
Yukiko Nishiyama's contributions to cancer research through her innovative patents highlight her role as a leading inventor in the field. Her work not only addresses critical challenges in cancer treatment but also inspires future research endeavors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile